Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)

DB14560ApprovedWithdrawnVaccines

Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated) is an influenza antigen used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval: United States, 2018

Resolves to

Compound

UNIID34GZG36OC

What you can answer from here — as of April 02, 2025

4ContraindicationsEach with its own population and attribute set

4Marketed productsAcross 2 countries and 2 labellers

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account